Ambien News and Research RSS Feed - Ambien News and Research

Study shows that abuse of anti-anxiety, sleep drugs becomes a growing issue among teens

Study shows that abuse of anti-anxiety, sleep drugs becomes a growing issue among teens

The medical community may be inadvertently creating a new generation of illegal, recreational drug users by prescribing anti-anxiety or sleep medications to teenagers, say University of Michigan researchers. [More]
Study on cancer care offers model for possible lower spending on treatment

Study on cancer care offers model for possible lower spending on treatment

The study, however, raised some questions because while it cut costs by a third and showed no decline in patient health, the spending on chemotherapy medications rose. [More]
Longer looks: Women's advantages in health law; health effects of the 'American Dream'

Longer looks: Women's advantages in health law; health effects of the 'American Dream'

Every week reporter Ankita Rao selects interesting reading from around the Web. [More]
One in six fatal traffic accidents results from drowsy driving, show reports

One in six fatal traffic accidents results from drowsy driving, show reports

Many of us make light of that relatively short drive home. But getting behind the wheel when you're sleepy can cost lives and lead to imprisonment and a hefty fine. [More]
Soligenix announces personalized medicine collaboration with SciClone

Soligenix announces personalized medicine collaboration with SciClone

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense countermeasures where there remains an unmet medical need, announced a personalized medicine collaboration with SciClone Pharmaceuticals in the Company's oral mucositis clinical program with SGX942. [More]
Research: Sleep mechanism enables brain to consolidate emotional memory

Research: Sleep mechanism enables brain to consolidate emotional memory

Sleep researchers from University of California campuses in Riverside and San Diego have identified the sleep mechanism that enables the brain to consolidate emotional memory and found that a popular prescription sleep aid heightens the recollection of and response to negative memories. [More]
New report finds sharp increase in emergency department visits involving adverse reactions to zolpidem

New report finds sharp increase in emergency department visits involving adverse reactions to zolpidem

A new report shows that the number of emergency department visits involving adverse reactions to the sleep medication zolpidem rose nearly 220 percent from 6,111 visits in 2005 to 19,487 visits in 2010. [More]
Research findings could lead to new sleep therapies to improve memory disorders

Research findings could lead to new sleep therapies to improve memory disorders

A team of sleep researchers led by UC Riverside psychologist Sara C. Mednick has confirmed the mechanism that enables the brain to consolidate memory and found that a commonly prescribed sleep aid enhances the process. [More]
FDA requires sleep drugs that contain zolpidem to lower recommended doses

FDA requires sleep drugs that contain zolpidem to lower recommended doses

The U.S. Food and Drug Administration today announced it is requiring the manufacturers of Ambien, Ambien CR, Edluar and Zolpimist, widely used sleep drugs that contain the active ingredient zolpidem, to lower current recommended doses. Ambien and Ambien CR are also available as generics. [More]
Somnogen induces sleep in patients with primary hypersomnia

Somnogen induces sleep in patients with primary hypersomnia

Researchers at Emory University School of Medicine have discovered that dozens of adults with an elevated need for sleep have a substance in their cerebrospinal fluid that acts like a sleeping pill. [More]
Obesity appears to increase risk of mortality tied to sleeping pills

Obesity appears to increase risk of mortality tied to sleeping pills

Obesity appears to significantly increase the risk of death tied to sleeping pills, nearly doubling the rate of mortality even among those prescribed 18 or fewer pills in a year, researchers reported Friday. [More]
Sleep specialists offer advice on why Daylight Saving Time can be hazardous to health

Sleep specialists offer advice on why Daylight Saving Time can be hazardous to health

It's National Sleep Awareness Week, and Loyola University Health System sleep specialists are offering advice on -- Why Daylight Saving Time, which begins Sunday, March 11, can be hazardous to your health. [More]
Sleeping pills may raise risk of death: Study

Sleeping pills may raise risk of death: Study

According to a U.S. study, people who take certain prescription sleeping pills even once in a while may be up to five times more susceptible to early death. In the U.S., an estimated six per cent to 10 per cent of adults used the drugs in 2010. [More]
Sleeping pills may increase risk of cancer-related death

Sleeping pills may increase risk of cancer-related death

People are relying on sleeping pills more than ever to get a good night's rest, but a new study by Scripps Clinic researchers links the medications to a 4.6 times higher risk of death and a significant increase in cancer cases among regular pill users. [More]
Longer looks: Romney and abortion politics

Longer looks: Romney and abortion politics

The heart attacks never came. Four days later, Chris woke up. It was not the awakening of Hollywood movies in which the patient comes to, just as he was, speaking full sentences and completely mobile. Three years later, Chris still cannot talk. Although he breathes on his own, his lungs battle a steady barrage of infections; a feeding tube provides all his sustenance, and his muscles have contracted into short, twisted knots. He can move only the slightest bit. … Still, Wayne and Judy say that his cognition is improving. [More]

Drug for midnight waking gets FDA approval

Transcept Pharmaceuticals Inc. has received the Food and Drug Administration (FDA) approval for its drug Intermezzo - a drug that can help people get back to sleep after waking in the middle of the night. The treatment contains a low-dose of zolpidem tartrate, the active ingredient in Paris-based Sanofi’s sleeping pill Ambien. [More]
Transcept receives FDA approval for Intermezzo to treat insomnia

Transcept receives FDA approval for Intermezzo to treat insomnia

The U.S. Food and Drug Administration today approved Intermezzo (zolpidem tartrate sublingual tablets) for use as needed to treat insomnia characterized by middle-of-the-night waking followed by difficulty returning to sleep. [More]

Actavis receives final FDA approval for Zolpidem ER Tablets

Actavis, an international generic pharmaceuticals company, today announced that it has received final approval from the US Food & Drug Administration to market Zolpidem Tartrate Extended-Release Tablets USP, 12.5 mg CIV. Distribution of the product has commenced. [More]
From fatigued to fantastic! You CAN effectively treat CFS, fatigue, fibromyalgia and muscle pain

From fatigued to fantastic! You CAN effectively treat CFS, fatigue, fibromyalgia and muscle pain

The “perfect storm” for Fibromyalgia, CFS/ME, and fatigue in general is preparing to hit. A combination of poor nutrition, decreasing sleep, increasing stress and environmental toxins has created a human energy crisis of unprecedented proportions. Over the past 10 years, the incidence of Chronic Fatigue Syndrome (CFS) and Fibromyalgia (FMS) has exploded by 400 to 1000 percent, as documented in five separate studies. The numbers for those with CFS in the U.S., previously estimated at 500,000, are now being re-tallied at closer to 1- 2.5 million. Previous estimates placed the number of Americans with FMS at 6 million. Studies worldwide suggest this has likely gone up in the last decade to ~ 12-24 million Americans! Meanwhile, ¼ of Americans suffer with chronic pain and most are fatigued. [More]
Sleep medications increase risk for nighttime falls and potential injury

Sleep medications increase risk for nighttime falls and potential injury

Adults who take one of the world's most commonly prescribed sleep medications are significantly more at risk for nighttime falls and potential injury, according to a new study by the University of Colorado at Boulder. [More]